India Pharma Outlook Team | Tuesday, 02 September 2025
Canon Medical Systems India Pvt. Ltd. has signed a Memorandum of Understanding (MoU) with Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) to enhance cancer diagnostics in India.
This MoU introduces RGCIRC will deploy Canon’s flagship 640-slice CT system, Aquilion ONE/INSIGHT Edition, for advanced research in cancer care.
The signing of the agreement based on the aspiration of Canon Medical's 'Made for Life', demonstrating an exemplary commitment to shaping healthcare innovation while improving standard of care.
Also Read: Role of Optical Imaging in Early Cancer Detection and Treatment
The Aquilion ONE/INSIGHT Edition includes wide-area (16-cm) coverage with deep learning Ai to achieve powerful diagnostic accuracy and efficiency.
Koh Yamada, president and CEO of Canon Medical Systems India Pvt Ltd said, “At Canon, we are committed to improving patient care through innovative technology based on the ‘Made for Life’ philosophy. We are very honoured to be contributing to support healthcare in India with this great opportunity given by Rajiv Gandhi Cancer Institute & Research Centre.”
Dr Sudhir Rawal, medical director & director surgical oncology of Rajiv Gandhi Cancer Institute & Research Centre states, “As a top cancer research centre we continuously invest in cutting edge technology and we look forward to use this collaboration to advance the cancer care paradigm in India.’’
Dr Sunil Kumar Puri, director, radiology & interventional oncology of Rajiv Gandhi Cancer Institute & Research Centre states, “We are pleased and excited to be first centre in India to work with this new system and we trust this innovative system will bring significant contributions for cancer diagnosis and improving our diagnostic confidence in the results.”
The Aquilion ONE/INSIGHT Edition has new innovations including Precise IQ Engine (PIQE), Advanced intelligent Clear-IQ Engine (AiCE), SilverBeam Filter, and the AI-powered INSTINX platform.
